Table 1 Roles of CIN in cancer
From: The two sides of chromosomal instability: drivers and brakes in cancer
Phenotype | Model | CIN indicators | Mechanism | Ref |
|---|---|---|---|---|
Tumor-promoting | AAA-Cdc20 heterozygous MEFs | Increased aneuploidy | Weakened SAC function | |
Tumor-promoting | ApcMin/+BubR1+/–mice | Increased aneuploidy, polyploidy, sister chromatid premature separation | Weakened SAC function | |
Tumor-promoting | AURKA-overexpressed mice | Increased aneuploidy, polyploidy, chromosome missegregation, sister chromatid premature separation | Centrosome amplification | |
Tumor-promoting | BUB1 haploinsufficient mice | Increased aneuploidy and chromosome missegregation | Weakened SAC function | |
Tumor-promoting | BUB3 haploinsufficient MEFs | Increased aneuploidy, sister chromatid premature separation | Weakened SAC function | |
Tumor-promoting | BUBR1 haploinsufficient mice | Increased polyploidy | Weakened SAC function | |
Tumor-promoting | Cyclin B-overexpressed MEFs | Increased aneuploidy, chromosome missegregation | Prolonged mitotic exit | |
Tumor-promoting | CENP-E heterozygous MEFs | Increased aneuploidy, polyploidy, chromosome missegregation | Microtubule-kinetochore attachment error | |
Tumor-promoting | HEC1-overexpressed mice | Increased aneuploidy, polyploidy, chromosome breaks | SAC hyperactivation | |
Tumor-promoting | MAD1 heterozygous deletion mice | Increased aneuploidy | Weakened SAC function | |
Tumor-promoting | MAD2 haploinsufficient cells | Increased aneuploidy, sister chromatid premature separation, chromosome missegregation | Weakened SAC function | |
Tumor-promoting | Securin homozygous deletion mice | Increased aneuploidy, polyploidy, sister chromatid premature separation | Premature sister chromatid separation | |
Tumor-promoting | TPX2 heterozygous mice | Increased aneuploidy, chromosome missegregation, | Disrupted normal microtubule polymerization | |
Tumor-promoting | UbcH10-overexpressed mice | Increased aneuploidy, chromosome missegregation, centrosome amplification | Premature sister chromatid separation | |
Tumor-suppressing | CDH1 heterozygous mice | Increased replication stress, aneuploidy, polyploidy, | Prolonged mitosis | |
Tumor-suppressing | STAG1 heterozygous deletion mice | Increased aneuploidy, polyploidy, chromosome missegregation | Impaired sister chromatid segregation | |
Tumor-suppressing | MAD2-overexpressed MEFs | Increased aneuploidy, polyploidy, chromosomal breaks | SAC hyperactivation | |
Tumor-suppressing | α-GSU PTTG-overexpressed mice | Increased aneuploidy, polyploidy, sister chromatid premature separation | Prolonged mitosis | |
Tumor-suppressing | PLK1 overexpressed mice | Increased polyploidy, lagging chromosome, sister chromatid premature separation, micronucleus, cytokinesis failure | SAC hyperactivation | |
Tumor-suppressing | MAD2 overexpression | Increased lagging chromosome, micronucleus, polyploidy | SAC hyperactivation | |
Tumor-suppressing | Ionizing radiation-exposed cells | Increased lagging chromosome, micronucleus | DNA DSBs | |
Tumor-suppressing | Paclitaxel-treated cells | Increased multipolar spindles, lagging chromosome | Prolonged mitosis |